Wrap Text
Interim Group Results for the six months ended 28 February 2021 and cash dividend declaration
Clicks Group Limited
(Incorporated in the Republic of South Africa)
Registration number: 1996/000645/06
JSE share code: CLS
ISIN: ZAE000134854
CUSIP: 18682W205
LEI: 378900E967958A677472
("Clicks Group" or "the group")
INTERIM GROUP RESULTS FOR THE SIX MONTHS ENDED 28 FEBRUARY 2021 AND CASH DIVIDEND DECLARATION
SHORT-FORM ANNOUNCEMENT
KEY FEATURES
- Group turnover up 7.6%
- Retail health and beauty sales up 7.2%
- UPD turnover up 9.0%
- Diluted headline earnings per share up 9.5%
- Interim dividend of 142.5 cents per share
- R1.7 billion returned to shareholders in dividends and buy-backs
- Cash of R1.1 billion at period-end
COMMENTARY
Overview
The strength and resilience of the group's business model has again been demonstrated in the
six months to February 2021 as the business continued to encounter the destructive impact of
Covid-19 and the related restrictions which have changed consumer shopping patterns and
significantly reduced customer footfall in malls.
Retail health and beauty sales increased by 7.2%, supported by strong front shop health sales
growth of 24.7%. UPD grew turnover by 9.0% and continued to gain market share, driven by the
robust growth in the hospital channel during the pandemic and by attracting new wholesale business.
The comparable reporting period was not impacted by Covid-19 and included an additional trading
day for the leap year in 2020.
In January 2021 the group announced the closure of Musica with effect from 31 May 2021. The closure
of the brand has been managed in a responsible and phased manner to mitigate the impact on
shareholders, employees and suppliers.
The resilient retail health and beauty and UPD performances, moderated by the closure of Musica,
contributed to diluted headline earnings per share (HEPS) increasing by 9.5% to 371 cents.
Excluding the impact of Musica, the group's diluted HEPS would have increased by 14.1%.
An interim cash dividend of 142.5 cents per share has been declared.
Financial performance
Group turnover increased by 7.6% to R18.1 billion. Retail sales grew by 5.8% and by 3.7% in
comparable stores, with selling price inflation of 3.3%. Distribution turnover increased by 9.0%
with price inflation of 2.3% for the half-year.
Total income grew by 5.7% to R4.9 billion with the total income margin 50 basis points lower at
26.8%. Within retail, the health and beauty margin was 40 basis points lower owing to the impact
of sales category mix changes, in particular declines in the high margin beauty category due to
the Covid-19 pandemic. The distribution margin strengthened by 40 basis points to 8.5% due to the
benefit of new wholesale and bulk distribution contracts gained in the previous year.
Stringent cost management contributed to the growth in expenses being contained to 4.2%. Retail
costs grew by only 3.1%, with comparable health and beauty costs being held in line with the
prior year. Distribution costs increased by 13.5%, well below the 18.9% growth in UPD's total
managed turnover.
Group operating profit increased by 9.7% to R1.4 billion with the group's operating margin
expanding by 10 basis points to 7.5% despite the impact of Covid-19 on the trading environment.
Headline earnings grew by 8.1% to R920 million. Earnings per share increased by 6.2% to 359 cents
with headline earnings per share increasing by 9.5% to 371 cents. Diluted headline earnings per
share grew by 9.5%.
Group inventory days improved by one day to 83 days. Retail inventory levels were 9.7% higher as
management increased front shop stock to mitigate the ongoing disruption in the local and global
supply chain. UPD stock cover has been managed to enable the business to respond to a possible
third wave of Covid-19 infections.
Cash generated by operating activities before dividends paid totalled R1.3 billion and increased
by 11.5% on the prior year. The group returned R1.1 billion to shareholders in dividend payments
and R602 million in share buy-backs. At the February 2021 period-end, the group held cash resources
of R1.1 billion.
Trading performance
Retail health and beauty sales, including Clicks and the international franchise brands GNC,
The Body Shop and Claire's, increased by 7.2%, driven by competitive everyday pricing,
differentiated product ranges, the Clicks ClubCard, new stores and online sales. Sales in
comparable stores increased by 4.0% with selling price inflation averaging 3.2%.
Clicks opened 17 stores in the first six months to expand its retail footprint to 760 stores.
The brand opened its 600th pharmacy in February 2021 and increased its national presence to
601 pharmacies with the opening of 16 pharmacies.
UPD grew wholesale turnover by 13.8% as the business gained new private hospital business.
This contributed to UPD increasing its market share from 27.2% to 30.6% at February 2021
(source IQVIA). UPD's total managed turnover, combining wholesale and bulk distribution,
increased by 18.9% to R13.2 billion.
Outlook
Trading conditions are expected to remain challenging as the group continues to operate in a
Covid-19 impacted environment, with the potential risk of a third wave of infections in the
months ahead.
The current economic climate has presented opportunities for new retail space and Clicks plans to
accelerate its store expansion programme with the opening of 40 new stores, 36 pharmacies and
40 refurbishments for the year.
UPD's largest distribution client has extended its contract for a further five years while the
business has gained an additional bulk distribution contract which will commence in the second
half of the year.
Capital investment of R745 million is planned for the financial year, focused on the store and
pharmacy network as well as IT systems and supply chain infrastructure.
Clicks Group is working closely with government departments and organisations involved in the
national vaccine roll-out programme to provide support through both Clicks and UPD.
Clicks has a network of over 600 pharmacies and 192 clinics across the country, to support the
programme, with capacity to administer between 600 000 and 700 000 vaccinations each month.
To date a total of 62 Clicks pharmacies have been registered by the Department of Health to assist
in phase 1 of the programme which involves the vaccination of healthcare workers. UPD is the
country's largest national pharmaceutical wholesaler and has the capability and infrastructure to
assist in the distribution of all temperature sensitive vaccines.
The roll-out of the vaccination programme is expected to aid the recovery of the economy.
The group has a robust balance sheet, generates strong cash flows and is well positioned for growth
as the trading environment improves.
FULL-YEAR EARNINGS FORECAST
The directors forecast that diluted HEPS for the financial year ending 31 August 2021 will increase
by between 8% and 13% over the 2020 financial year.
This forecast assumes that the current constrained trading environment will be sustained into the
second half of the 2021 financial year and continue to be impacted by Covid-19.
The forecast does not take account of any trading restrictions which may be imposed by government
in response to a possible third wave of infections in the months ahead. The forecast also does not
consider any potential impact from the group's retail and distribution businesses' participation in
the national Covid-19 vaccination programme.
Shareholders are advised that this forecast is the responsibility of the board of directors and
has not been reviewed or reported on by the group's independent auditor.
INTERIM DIVIDEND
The board of directors has approved an interim gross ordinary dividend for the period ended
28 February 2021 of 142.5 cents per share (2020: nil cents per share). The source of the dividend
will be from distributable reserves and it will be paid in cash.
Additional information
Dividends Tax (DT) of 20% amounting to 28.5 cents per ordinary share will be withheld in terms of
the Income Tax Act. Ordinary shareholders who are not exempt from DT will therefore receive a
dividend of 114.0 cents net of DT.
The company has 246 168 326 ordinary shares in issue. Its income tax reference number
is 9061/745/71/8.
Shareholders are advised of the following salient dates in respect of the interim dividend:
Last day of trade "cum" the dividend Tuesday, 29 June 2021
Shares trade "ex" the dividend Wednesday, 30 June 2021
Record date Friday, 2 July 2021
Payment to shareholders Monday, 5 July 2021
Share certificates may not be dematerialised or rematerialised between Wednesday, 30 June 2021 and
Friday, 2 July 2021, both days inclusive.
Shareholders who have in the past received dividend payments by cheque will no longer be able to
do so and are advised to contact the company secretary at companysecretary@clicksgroup.co.za to
arrange for an alternative payment method.
David Nurek Vikesh Ramsunder Michael Fleming
Chairman Chief executive officer Chief financial officer
Cape Town
22 April 2021
This short-form announcement is the responsibility of the Clicks Group board of directors
and is a summary of the information in the detailed interim results announcement and does
not contain full or complete details. The full announcement can be downloaded from
https://senspdf.jse.co.za/documents/2021/jse/isse/CLS/H1results.pdf or on the group's website
at http://www.clicksgroup.co.za. The announcement is available for inspection, at no charge, at the
company's registered office during business hours for a period of 30 calendar days following
the date of this announcement. Any investment decision in relation to the company's shares
should be based on the full announcement.
Directors: DM Nurek* (Chairman), F Abrahams*, JA Bester*, F Daniels*, BD Engelbrecht, M Fleming
(Chief Financial Officer), PM Moumakwa*#, MJN Njeke*, V Ramsunder (Chief Executive Officer), M Rosen*
* Independent non-executive
# Appointed 1 April 2021
Registered office: Cnr Searle and Pontac Streets, Cape Town 8001
Transfer secretaries: Computershare Investor Services (Proprietary) Limited
http://www.clicksgroup.co.za
Sponsor
Investec Bank Limited
Date: 22-04-2021 08:00:00
Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE').
The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of
the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct,
indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on,
information disseminated through SENS.